Stock Events

Stock Events

Search...

Corvus Pharmaceuticals (C17.F) Q3 2024 Earnings

6AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.13

-0.1

-0.08

-0.06

Details

Expected EPS

-0.1052549

Actual EPS

-0.0640682

Surprise EPS

0.04

Surprise Percent

+39.13%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.0640682 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.